Serum and tissue selenium levels in gastric cancer patients and correlation with CEA
dc.contributor.author | Charalabopoulos, K. | en |
dc.contributor.author | Kotsalos, A. | en |
dc.contributor.author | Batistatou, A. | en |
dc.contributor.author | Charalabopoulos, A. | en |
dc.contributor.author | Peschos, D. | en |
dc.contributor.author | Vezyraki, P. | en |
dc.contributor.author | Kalfakakou, V. | en |
dc.contributor.author | Metsios, A. | en |
dc.contributor.author | Charalampopoulos, A. | en |
dc.contributor.author | Macheras, A. | en |
dc.contributor.author | Agnantis, N. | en |
dc.contributor.author | Evangelou, A. | en |
dc.date.accessioned | 2015-11-24T18:52:12Z | |
dc.date.available | 2015-11-24T18:52:12Z | |
dc.identifier.issn | 1791-7530 | - |
dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/18371 | |
dc.rights | Default Licence | - |
dc.subject | Adenocarcinoma/*metabolism/secondary | en |
dc.subject | Carcinoembryonic Antigen/*blood | en |
dc.subject | Case-Control Studies | en |
dc.subject | Female | en |
dc.subject | Fluorometry | en |
dc.subject | Humans | en |
dc.subject | Immunoenzyme Techniques | en |
dc.subject | Immunoradiometric Assay | en |
dc.subject | Intestinal Neoplasms/*metabolism/pathology | en |
dc.subject | Male | en |
dc.subject | Middle Aged | en |
dc.subject | Neoplasm Staging | en |
dc.subject | Prognosis | en |
dc.subject | Selenium/*metabolism | en |
dc.subject | Stomach Neoplasms/*metabolism/pathology | en |
dc.subject | Tumor Markers, Biological/*blood | en |
dc.title | Serum and tissue selenium levels in gastric cancer patients and correlation with CEA | en |
heal.abstract | BACKGROUND: An inverse relationship between selenium (Se) intake and cancer mortality is evident in humans. MATERIALS AND METHODS: In eighty patients who had been operated on for primary gastric cancer, serum Se and carcinoembryonic antigen (CEA) levels were measured preoperatively using a fluorometric and immunoradiometric assay (IRMA), respectively. RESULTS: The serum Se levels were 43+/-6.3 microg l(-1) in the patient group and 68.7+/-4.5 microg l(-1) in healthy individuals (p<0.001). The serum CEA was 12+/-1.9 U ml(-1) in the gastric cancer patients and 2.1 U ml(-1) in the control group (p<0.001). The Se tissue concentrations were 2,640+/-220 mg g(-1) in excised neoplastic tissue and 685+/-115 mg g(-1) in non-neoplastic tissue (p<0.001). An inverse correlation between Se and CEA serum levels was found (r=-0.782). There was no correlation between serum/tissue Se concentration and disease stage/histological type or gender in the patient group. | en |
heal.access | campus | - |
heal.fullTextAvailability | TRUE | - |
heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/19661375 | - |
heal.journalName | Anticancer Res | en |
heal.journalType | peer-reviewed | - |
heal.language | en | - |
heal.publicationDate | 2009 | - |
heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
heal.type | journalArticle | - |
heal.type.el | Άρθρο Περιοδικού | el |
heal.type.en | Journal article | en |
Αρχεία
Φάκελος/Πακέτο αδειών
1 - 1 of 1
Φόρτωση...
- Ονομα:
- license.txt
- Μέγεθος:
- 1.74 KB
- Μορφότυπο:
- Item-specific license agreed upon to submission
- Περιγραφή: